Photobiomodulation Therapy for Serous Pigment Epithelium Detachment in Chronic Central Serous Chorioretinopathy.

Q3 Medicine
Claudio Iovino, Luciana Damiano, Valerio Piccirillo, Francesco Testa, Giuseppe Giannaccare, Francesca Simonelli
{"title":"Photobiomodulation Therapy for Serous Pigment Epithelium Detachment in Chronic Central Serous Chorioretinopathy.","authors":"Claudio Iovino, Luciana Damiano, Valerio Piccirillo, Francesco Testa, Giuseppe Giannaccare, Francesca Simonelli","doi":"10.1097/ICB.0000000000001665","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of giant pigment epithelium detachment (PED) secondary to chronic central serous chorioretinopathy (cCSC) successfully treated with photobiomodulation (PBM).</p><p><strong>Methods: </strong>Case report.</p><p><strong>Results: </strong>A 55-year-old man complained a worsening of vision in the left eye (LE) over the last 18 months.A complete ophthalmological evaluation encompassing best corrected visual acuity (BCVA) measurement, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF), fluorescein angiography (FA) and microperimetry (MP) was performed.SD-OCT showed several small PEDs around the macula in the right eye and a giant macular serous PED with subretinal fluid (SRF) in the LE. FA disclosed multiple hyperfluorescent roundish areas in the posterior pole bilaterally, with a macular pooling in the LE.A diagnosis of cCSC was made, and patient underwent PBM with one session for week for four weeks, followed by one session bi-weekly for two months.SD-OCT of the LE showed a gradual flattening of the macular PED at 3 months, with a complete regression of the latter and of the SRF at 6- and 12-month follow up with no residual signs of chorioretinal atrophy on FAF. BCVA improved from 20/80 at baseline to 20/25 at the last follow up, and this functional improvement was further confirmed by MP.</p><p><strong>Conclusions: </strong>PBM can be considered a safe and effective treatment strategy for the management of cCSC with SRF and serous PED.</p>","PeriodicalId":53580,"journal":{"name":"Retinal Cases and Brief Reports","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retinal Cases and Brief Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ICB.0000000000001665","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To report a case of giant pigment epithelium detachment (PED) secondary to chronic central serous chorioretinopathy (cCSC) successfully treated with photobiomodulation (PBM).

Methods: Case report.

Results: A 55-year-old man complained a worsening of vision in the left eye (LE) over the last 18 months.A complete ophthalmological evaluation encompassing best corrected visual acuity (BCVA) measurement, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF), fluorescein angiography (FA) and microperimetry (MP) was performed.SD-OCT showed several small PEDs around the macula in the right eye and a giant macular serous PED with subretinal fluid (SRF) in the LE. FA disclosed multiple hyperfluorescent roundish areas in the posterior pole bilaterally, with a macular pooling in the LE.A diagnosis of cCSC was made, and patient underwent PBM with one session for week for four weeks, followed by one session bi-weekly for two months.SD-OCT of the LE showed a gradual flattening of the macular PED at 3 months, with a complete regression of the latter and of the SRF at 6- and 12-month follow up with no residual signs of chorioretinal atrophy on FAF. BCVA improved from 20/80 at baseline to 20/25 at the last follow up, and this functional improvement was further confirmed by MP.

Conclusions: PBM can be considered a safe and effective treatment strategy for the management of cCSC with SRF and serous PED.

光生物调节疗法治疗慢性中央性浆液性脉络膜视网膜病变中的浆液性色素上皮脱落。
目的:报道1例继发于慢性中枢性浆液性脉络膜视网膜病变(cCSC)的巨色素上皮脱离(PED)经光生物调节(PBM)成功治疗。方法:病例报告。结果:一名55岁男性主诉在过去的18个月里左眼视力恶化。进行了完整的眼科评估,包括最佳矫正视力(BCVA)测量、光谱域光学相干断层扫描(SD-OCT)、眼底自身荧光(FAF)、荧光素血管造影(FA)和显微视力(MP)。SD-OCT显示右眼黄斑周围可见数个小PED,左眼可见巨大黄斑浆液性PED伴视网膜下液。FA显示双侧后极有多个高荧光圆形区域,LE有黄斑池。诊断为cCSC,患者接受PBM治疗,每周一次,持续四周,随后每两周进行一次,持续两个月。LE的SD-OCT显示黄斑PED在3个月时逐渐变平,后者和SRF在6个月和12个月的随访中完全消退,FAF上没有残留的绒毛膜视网膜萎缩迹象。BCVA从基线时的20/80改善到末次随访时的20/25,MP进一步证实了这一功能改善。结论:PBM可被认为是治疗伴有SRF和严重PED的cCSC的一种安全有效的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Retinal Cases and Brief Reports
Retinal Cases and Brief Reports Medicine-Ophthalmology
CiteScore
2.10
自引率
0.00%
发文量
342
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信